Insights from 2023 ASCO® Annual Meeting
T

ASCO® 2023 Insights: "Final Prespecified OS Analysis of CLEAR - 4-Year Follow-Up of Lenvatinib + Pembro vs. Sunitinib in Patients With Advanced RCC"

By Insights from 2023 ASCO® Annual Meeting FEATURING Thomas Hutson
By Insights from 2023 ASCO® Annual Meeting FEATURING Thomas Hutson
300 views
June 27, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

17:48
Exelixis

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma With Mul…

Feat. R. Alter, A. Rezazadeh

Featured Video

19:38
Exelixis

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma and Qual…

Feat. R. Alter, A. Rezazadeh

Recommended

RENALC-BLADDR-PROSCA 2024

RENALC 2024 - Hybrid Global Forum on GU Oncology

Tue, Nov 26, 2024
16:05

Recent GU Developments and Their Clinical Implications

Insights from 2024 ASCO® GU Annual Meeting

T. Powles, B. Rini

1.5K views

·

8 months ago
17:50

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

1.8K views

·

6 months ago
29:25

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

1.2K views

·

6 months ago
13:37

SIR 2023: Renal Cell Carcinoma Guidelines - What's New in 2023?

SIR 2023 Conference Coverage

N. Kothary

3.0K views

·

1 year ago
15:58

Best of Bladder Cancer and RCC From ESMO 2023 and GU ASCO 2024

Total Health

M. Reimers

528 views

·

8 months ago
10:19

ASCO® 2024 Summary: "Current Updates in RCC - Clinical Implications …

2024 ASCO® Annual Meeting Insights Hub

K. Mittal

362 views

·

3 months ago
07:27

Opus One: Final Results - RFA in Axial Skeleton

Jason Levy

2.0K views

·

1 year ago
15:28

ASCO® 2024 Summary: "Bladder and RCC Highlights"

2024 ASCO® Annual Meeting Insights Hub

K. Tawagi, N. Reizine

261 views

·

3 months ago
20:07

New

ESMO 2024 Summary: Developmental Therapeutics Highlights

2024 ESMO Annual Meeting Insights Hub

G. Sonpavde

222 views

·

2 weeks ago
06:41

No Role to Continue ICI Beyond Progression: CONTACT-03 & TiNivo-2 Ph…

Dana-Farber Cancer Institute

B. McGregor

130 views

·

1 month ago
06:58

ASCO® 2024 Insights: "Systemic Treatments in Favorable and Very Favo…

2024 ASCO® Annual Meeting Insights Hub

M. Zarba

242 views

·

5 months ago
13:46

Overview of a SoC in 1L mRCC Focusing on the Long-Term Survival Data

David McDermott

245 views

·

6 months ago
19:41

How I Manage Immune Adverse Events in Solid Tumors

Balazs Halmos

1.9K views

·

1 year ago
16:14

ESMO 2024 Summary: Important GU Trials - ETER100 (RCC), TACITO (mRCC…

2024 ESMO Annual Meeting Insights Hub

C. Porta

174 views

·

1 month ago
22:03

RCC Highlights From ASCO® GU 2024

Dana-Farber Cancer Institute

W. Xu, T. Choueiri

331 views

·

8 months ago
19:00

New

Treatment (De)Intensification in RCC

International Urology Cancer Summit - IUCS

S. Kumar Pal

123 views

·

3 weeks ago
06:33

ESMO 2024 Insights: TACITO Trial - Fecal Microbiota Transplantation …

2024 ESMO Annual Meeting Insights Hub

C. Ciccarese

154 views

·

1 month ago
17:33

1L Treatment Approaches in aRCC: Current Data, Treatment Selection, …

Benjamin Garmezy

251 views

·

6 months ago
06:49

ASCO® 2024 Insights: "Belzutifan for Advanced Renal Cell Carcinoma"

2024 ASCO® Annual Meeting Insights Hub

E. Jonasch

196 views

·

5 months ago
06:55

ESMO 2024 Insights: SC vs. IV Nivolumab in Advanced/Metastatic RCC -…

2024 ESMO Annual Meeting Insights Hub

L. Albiges

113 views

·

1 month ago
AUTOPLAY